Virulence of coagulase-deficient mutants of Staphylococcus aureus in experimental endocarditis

Journal of Medical Microbiology
L M BaddourT J Foster

Abstract

A sensitive rat endocarditis model which employed relatively small inocula (< or = 10(4) cfu) was used to examine the role of coagulase in the pathogenesis of infection. Rats with indwelling, intracardiac catheters were challenged intravenously with three strains of Staphylococcus aureus. The virulence of a coagulase-positive parental strain DU5808 was compared in terms of its ID50 for resected vegetations and catheters to that of two coagulase-negative mutant strains (DU5809 and DU5814) which had undergone site-specific mutagenesis. Confidence intervals of infection rates were calculated and comparisons were performed of weights of infected vegetations, bacterial concentrations in vegetations and early mortality rates. From these virulence parameters, it was concluded that there were no differences in virulence among the three strains. The results from this investigation support the previous findings in mouse models of subcutaneous infection and mastitis, which indicated that coagulase production by S. aureus does not appear to function as a virulence factor. Together, these data refute the longheld belief that coagulase is important in the pathogenesis of infection and indicate that other markers of virulence must be operativ...Continue Reading

Citations

Dec 2, 2011·Seminars in Immunopathology·Andrea DeDentOlaf Schneewind
Jun 17, 2011·Animal Health Research Reviews·Heba AtallaBonnie Mallard
Oct 6, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L M Baddour
Sep 3, 2010·Journal of Clinical Microbiology·Thomas VanasschePeter Verhamme
Nov 2, 2011·Journal of Thrombosis and Haemostasis : JTH·T VanasscheP Verhamme
Jul 3, 2002·Infectious Disease Clinics of North America·Philippe MoreillonArnold S Bayer
Feb 22, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Shahin NozohoorAnders Heimdahl
Nov 21, 1998·The Annals of Otology, Rhinology, and Laryngology·M A BielT M Tedford
Nov 23, 2018·Proceedings of the National Academy of Sciences of the United States of America·Urvish TrivediSøren J Sørensen
May 18, 2006·The International Journal of Artificial Organs·N HarraghyM Herrmann
Dec 19, 2017·Journal of Thrombosis and Haemostasis : JTH·L LiesenborghsT Vanassche
Jun 15, 2017·Frontiers in Cellular and Infection Microbiology·Haiyong GuoYinduo Ji
Jun 22, 1999·Infection and Immunity·R O NicholasD R Gentry
Sep 19, 1998·American Journal of Rhinology·J HsuD W Kennedy

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Heather K KrohPaul E Bock
Journal of Thrombosis and Haemostasis : JTH
A Hijikata-Okunomiya, N Kataoka
© 2021 Meta ULC. All rights reserved